Effect of Technology Enriched Rehabilitation After Stroke
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Strathclyde
About this trial
The Biomedical Engineering Dept, University of Strathclyde, co-creates rehabilitation technology. In 2023-2024 a clinical study (NCT06787768) was conducted to understand the feasibility of a multi-technology approach to rehabilitation early after stroke. This was successful and leads to the next phase which is to gather preliminary evidence of the effectiveness of this approach by monitoring change in the mobility of patients who receive this intervention compared with usual care which will be gathered through a data linkage project (tracking the outcomes from matched patients from other parts of Scotland who receive usual care).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of new stroke by NHS Lanarkshire physician
More than 48 hours since stroke event
Deemed medically fit for rehabilitation by medical staff
Deemed to require rehabilitation
Disqualifiers
Acutely medically unwell
Active cardiac disease, such as unstable angina
Active delirium/significant levels of confusion
Seizure within past 7 days
Trial design
Design model
Single group
Treatments tested in this trial
Technology Enriched Rehabilitation
Other interventionThe intervention is a rehabilitation programme delivered entirely through technology, including virtual reality (immersed and non-immersed), treadmills, weight suspension and movement resistance, and power assistance equipment located in a gym-like space on an acute stroke unit (NHS Lanarkshire). Individual programs are designed and reviewed by a physiotherapist using principles of intensity, feedback, cognitive engagement, and aerobic activity to address the goals identified by the participant and scores from outcome measures at baseline. Attendance at the gym is supervised and assisted by rehabilitation support workers. Participants can attend daily for 2 hours maximum until discharge, according to their tolerance and judgement of the clinical ward team.
Treatment groups
62 Participants
are divided into 1 treatment groupGroup A: Technology Enriched RehabilitationExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Modified Rivermead Mobility Index (MRMI)
The Modified Rivermead Mobility Index (MRMI) is a standardized 8-item assessment that evaluates mobility tasks including turning over, balance, transfers, walking, and stair climbing. Scores range from 0 to 40, with higher scores indicating greater mobility. The items include: Turning over Lying to sitting Sitting balance Sitting to standing Standing Transfers Walking indoors Stairs
Time frame
Baseline (between consent and start of intervention) and immediately before hospital discharge.Secondary outcomes
1
10-Metre Walk Test (10MWT)
A standardized assessment of gait speed over a 10-metre distance. Faster times indicate better walking ability.
Time frame
Baseline (between consent and start of intervention) and immediately before hospital discharge.2
Five Times Sit-to-Stand Test (FTSTST)
A functional lower-limb strength and mobility test measuring the time required to stand up from a seated position five times. Shorter times indicate better performance.
Time frame
Baseline (between consent and start of intervention) and immediately before hospital discharge.3
Berg Balance Scale (BBS)
A 14-item scale assessing static and dynamic balance. Scores range from 0 to 56, with higher scores indicating better balance.
Time frame
Baseline (between consent and start of intervention) and immediately before hospital discharge.4
Action Research Arm Test (ARAT)
A standardized 19-item measure of upper-limb function assessing grasp, grip, pinch, and gross arm movement. Scores range from 0 to 57; higher scores indicate better arm function.
Time frame
Baseline (between consent and start of intervention) and immediately before hospital discharge.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Strathclyde
Lead sponsor
NHS Lanarkshire
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: